Back

Generation of antigen-specific paired chain antibody sequences using large language models

Wasdin, P. T.; Johnson, N. V.; Janke, A. K.; Held, S.; Marinov, T. M.; Jordaan, G.; Vandenabeele, L.; Pantouli, F.; Gillespie, R. A.; Vukovich, M. J.; Holt, C. M.; Kim, J.; Hansman, G.; Logue, J.; Chu, H. Y.; Andrews, S. F.; Kanekiyo, M.; Sautto, G. A.; Ross, T. M.; Sheward, D. J.; McLellan, J. S.; Abu-Shmais, A. A.; Georgiev, I. S.

2025-02-17 bioinformatics
10.1101/2024.12.20.629482 bioRxiv
Show abstract

The traditional process of antibody discovery is limited by inefficiency, high costs, and low success rates. Recent approaches employing artificial intelligence (AI) have been developed to optimize existing antibodies and generate antibody sequences in a target-agnostic manner. In this work, we present MAGE (Monoclonal Antibody GEnerator), a sequence-based Protein Language Model (PLM) fine-tuned for the task of generating paired human variable heavy and light chain antibody sequences against targets of interest. We show that MAGE can generate novel and diverse antibody sequences with experimentally validated binding specificity against SARS-CoV-2, an emerging avian influenza H5N1, and respiratory syncytial virus A (RSV-A). MAGE represents a first-in-class model capable of designing human antibodies against multiple targets with no starting template.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.